Vijay Chiruvolu
Directeur Technique/Scientifique/R&D chez TURNSTONE BIOLOGICS CORP.
Fortune : - $ au 30/04/2024
Postes actifs de Vijay Chiruvolu
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| TURNSTONE BIOLOGICS CORP. | Directeur Technique/Scientifique/R&D | 01/03/2023 | - |
Historique de carrière de Vijay Chiruvolu
Anciens postes connus de Vijay Chiruvolu
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| INSTIL BIO, INC. | Directeur Technique/Scientifique/R&D | 01/07/2020 | 02/09/2022 |
| KITE PHARMA INC | Corporate Officer/Principal | - | - |
Formation de Vijay Chiruvolu
| The University of Nebraska-Lincoln | Doctorate Degree |
| The Pennsylvania State University | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| INSTIL BIO, INC. | Health Technology |
| TURNSTONE BIOLOGICS CORP. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Bourse
- Insiders
- Vijay Chiruvolu
- Expérience
